ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements
Saroja Pharma's statutory auditor Pravin Chandak & Associates resigned effective October 26, 2026, citing pre-occupation. The company will appoint new auditors to fill the vacancy.
Mr. Ravindra Shivaji Salaskar has resigned as Whole-time Director of Saroja Pharma Industries India Limited, effective October 5, 2026. He continues as the company's CFO.
Saroja Pharma Industries India Limited held its 8th Annual General Meeting on September 30, 2026, through video conferencing to transact business.
Saroja Pharma Industries India Limited appointed Mr. Ravindra Shivaji Salaskar as Chief Financial Officer. He currently serves as a Whole-time Director of the company.
Saroja Pharma Industries India Limited has issued a notice for its 8th Annual General Meeting, scheduled to be held on September 30, 2026, through video conferencing.
Saroja Pharma Industries approved its draft Board Report, Management Discussion and Analysis Report, and the notice for its 8th Annual General Meeting.
Saroja Pharma announced the re-designation of Mr. Pulinattu Damodaran Nandakumar as Whole-time Director and the appointment of Mr. Niraj Variava as Internal Auditor.
Saroja Pharma confirms zero deviation in utilizing ₹9.11 Crore raised via IPO. The funds were fully deployed for manufacturing setup, debt repayment, and issue expenses.
Saroja Pharma Industries India Limited submitted its annual SDD compliance certificate for FY2026. The auditor confirmed full compliance with SEBI insider trading database requirements.
Saroja Pharma Industries India Ltd reported revenue from operations of ₹31.8 Cr (-9.1% YoY) and net profit of ₹1 Cr (+42.9% YoY) for H2 FY26.
Saroja Pharma approved its FY2026 audited financial results, reporting an annual total income of ₹70.24 Crore. The board confirmed an unmodified auditor's opinion on these standalone figures.